Pharmacokinetics of n‐4‐hydroxyphenyl‐retinamide and the effect of its oral administration on plasma retinol concentrations in cancer patients
Authors:
- Frank L. MeyskensFMFrank L. Meyskens
- 15 January 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 43 (1) , 22-26
Abstract
Concurrent with a phase‐II trial of 4HPR in patients with various cancers, we studied the plasma pharmacokinetics of both 4HPR and its major metabolite 4MPR as well as the effect of 4HPR administration on plasma retinol concentrations using a simple, specific and sensitive HPLC procedure. Initial estimates of plasma pharmacokinetic parameters after oral administration of 4HPR (300 mg/m2) in 3 cancer patients were the following: 4HPR, tβ1/2 = 13.7 hr, AUC = 3.49 μg.hr/ml, CL = 56.57 L/hr/m2; 4MPR, tβ1/2 = 23.0 hr, AUC = 1.15 μg.hr/ml, CL = 239.29 L/hr/m2. We also found that oral administration of 4HPR resulted in a rapid, profound and significant reduction in plasma retinol concentrations. The mean plasma retinol concentrations for 9 patients decreased 60% from baseline to below 200 ng/ml within 1–2 weeks of 4HPR dosing initiation. In addition, there was a concurrent, significant reduction in plasma retinol‐binding protein levels in these patients. The mechanism whereby 4HPR reduces plasma retinol levels in vivo has not been determined. The addition of 4HPR to pooled human plasma at 37°C in vitro did not reduce endogenous retinol levels, suggesting no direct chemical interaction between these 2 retinoids.Keywords
This publication has 9 references indexed in Scilit:
- Retinoids and Mammary Gland Differentiation1985
- Effect of 13‐cis‐retinoic acid and 4‐hydroxyphenyl‐all‐trans‐retinamide on human tumor colony formation in soft agarInternational Journal of Cancer, 1983
- Influence of 15 retinoic acid amides on urinary bladder carcinogenesis in the mouseCarcinogenesis, 1982
- FROM VITAMIN A TO RETINOIDS IN EXPERIMENTAL AND CLINICAL ONCOLOGY: ACHIEVEMENTS, FAILURES, AND OUTLOOKAnnals of the New York Academy of Sciences, 1981
- Comparative Subacute Toxicity of Retinyl Acetate and Three Synthetic Retinamides in Swiss Mice2JNCI: Journal of the National Cancer Institute, 1979
- Retinoids, a new class of compounds with prophylactic and therapeutic activities in oncology and dermatologyCellular and Molecular Life Sciences, 1978
- CSTRIP, a Fortran IV Computer Program for Obtaining Initial Polyexponential Parameter EstimatesJournal of Pharmaceutical Sciences, 1976
- Experimental cancer of the lung.Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumorsCancer, 1967
- Immunochemical quantitation of antigens by single radial immunodiffusionImmunochemistry, 1965